Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 18/20 | 0.57 |
| ▸ | PIK3CD | O00329 | 16/20 | 0.54 |
| ▸ | PIK3CG | P48736 | 15/20 | 0.54 |
| ▸ | MTOR | P42345 | 10/20 | 0.53 |
| ▸ | PIK3R1 | P27986 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2535022 | 0.83 | KDM4E (0.40) | PIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL2535618 | 0.81 | PIK3CD (0.48) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 | |
| SCHEMBL2533298 | 0.79 | PIK3CA (0.52) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 | |
| SCHEMBL2532696 | 0.79 | CD38 (0.39) | PIK3CAPIK3CDPIK3CGPIK3R1 | |
| SCHEMBL2533306 | 0.79 | PIK3CA (0.42) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 | |
| SCHEMBL11862561 | 0.78 | PIK3CA (0.56) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 | |
| SCHEMBL11853830 | 0.78 | HRH4 (0.63) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 | |
| SCHEMBL2528796 | 0.78 | PIK3CA (0.37) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 | |
| SCHEMBL2531943 | 0.78 | TSHR (0.37) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 | |
| Hydrochloric Acid SCHEMBL11852640 | 0.77 | KDM4E (0.55) | PIK3CAPIK3CDPIK3CGMTORPIK3R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110257170-A1 | 4-MORPHOLINO-PYRIDO[3,2-D]PYRIMIDINES | MERCK SERONO SA (CH) | 2011-10-20 | — | — | US | disclosed |
| US-20110257170-A1 | 4-MORPHOLINO-PYRIDO[3,2-D]PYRIMIDINES | MERCK SERONO SA (CH) | 2011-10-20 | — | — | US | disclosed |
| US-20110257170-A1 | 4-MORPHOLINO-PYRIDO[3,2-D]PYRIMIDINES | MERCK SERONO SA (CH) | 2011-10-20 | — | — | US | disclosed |
| WO-2010037765-A2 | 4-MORPHOLINO-PYRIDO[3,2-D]PYRIMIDINES | MERCK SERONO S.A. (CH) | 2010-04-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257170-A1 | 4-MORPHOLINO-PYRIDO[3,2-D]PYRIMIDINES | PIK3CA, PIK3CD, PIK3CG | PIK3CA 1/4885PIK3CD 2/4885PIK3CG 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.